MRK Opens Wallet, VRX To Face FDA Panel In July, SPHS Vaults On Trial Data

Shares of Sophiris Bio Inc. (SPHS) were up over 124% in after-hours on Thursday, following encouraging results from a phase 2a proof of concept study of Topsalysin in localized prostate cancer.

from RTT - Biotech http://ift.tt/1Yh94iQ
via IFTTT